Critically Ill Patients with COVID-19: A Narrative Review on Prone Position.
- Published in:
- Pulmonary Therapy, 2020, v. 6, n. 2, p. 233, doi. 10.1007/s41030-020-00135-4
- By:
- Publication type:
- Article
Works matching IS 23641746 AND DT 2020 AND VI 6 AND IP 2
Results: 19
1
2
New Anti-Chemokine Oral Drug XC8 in the Treatment of Asthma Patients with Poor Response to Corticosteroids: Results of a Phase 2A Randomized Controlled Clinical Trial.
- Published in:
- Pulmonary Therapy, 2020, v. 6, n. 2, p. 351, doi. 10.1007/s41030-020-00134-5
- By:
- Publication type:
- Article
3
Switching Inhalers: A Practical Approach to Keep on UR RADAR.
- Published in:
- Pulmonary Therapy, 2020, v. 6, n. 2, p. 381, doi. 10.1007/s41030-020-00133-6
- By:
- Publication type:
- Article
4
Prescribing Pathways to Triple Therapy: A Multi-Country, Retrospective Observational Study of Adult Patients with Chronic Obstructive Pulmonary Disease.
- Published in:
- Pulmonary Therapy, 2020, v. 6, n. 2, p. 333, doi. 10.1007/s41030-020-00132-7
- By:
- Publication type:
- Article
5
General Practitioner Use of Generically Substitutable Inhaler Devices and the Impact of Training on Device Mastery and Maintenance of Correct Inhaler Technique.
- Published in:
- Pulmonary Therapy, 2020, v. 6, n. 2, p. 315, doi. 10.1007/s41030-020-00131-8
- By:
- Publication type:
- Article
6
The Lung Life of a Cystic Fibrosis Patient: A Patient and Physician Perspective.
- Published in:
- Pulmonary Therapy, 2020, v. 6, n. 2, p. 159, doi. 10.1007/s41030-020-00130-9
- By:
- Publication type:
- Article
7
Long-Term Ivacaftor in People Aged 6 Years and Older with Cystic Fibrosis with Ivacaftor-Responsive Mutations.
- Published in:
- Pulmonary Therapy, 2020, v. 6, n. 2, p. 303, doi. 10.1007/s41030-020-00129-2
- By:
- Publication type:
- Article
8
Correction to: Physiologically Based Pharmacokinetic Modeling of CFTR Modulation in People with Cystic Fibrosis Transitioning from Mono or Dual Regimens to Triple-Combination Elexacaftor/Tezacaftor/Ivacaftor.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
9
Assessment of Patient Experiences with Respimat<sup>®</sup> in Everyday Clinical Practice.
- Published in:
- Pulmonary Therapy, 2020, v. 6, n. 2, p. 371, doi. 10.1007/s41030-020-00127-4
- By:
- Publication type:
- Article
10
The Interplay Between Coagulation and Inflammation Pathways in COVID-19-Associated Respiratory Failure: A Narrative Review.
- Published in:
- Pulmonary Therapy, 2020, v. 6, n. 2, p. 215, doi. 10.1007/s41030-020-00126-5
- By:
- Publication type:
- Article
11
In Vitro Effect of Different Airflow Rates on the Aerosol Properties of Nebulized Glycopyrrolate in the eFlow® Closed System and Tiotropium Delivered in the HandiHaler®.
- Published in:
- Pulmonary Therapy, 2020, v. 6, n. 2, p. 289, doi. 10.1007/s41030-020-00125-6
- By:
- Publication type:
- Article
12
Physiologically Based Pharmacokinetic Modeling of CFTR Modulation in People with Cystic Fibrosis Transitioning from Mono or Dual Regimens to Triple-Combination Elexacaftor/Tezacaftor/Ivacaftor.
- Published in:
- Pulmonary Therapy, 2020, v. 6, n. 2, p. 275, doi. 10.1007/s41030-020-00124-7
- By:
- Publication type:
- Article
13
Procalcitonin for Antibiotic Prescription in Chronic Obstructive Pulmonary Disease Exacerbations: Systematic Review, Meta-Analysis, and Clinical Perspective.
- Published in:
- Pulmonary Therapy, 2020, v. 6, n. 2, p. 201, doi. 10.1007/s41030-020-00123-8
- By:
- Publication type:
- Article
14
Physical Functioning in Patients with Chronic Obstructive Pulmonary Disease Treated with Tiotropium/Olodaterol Respimat in Routine Clinical Practice in Italy.
- Published in:
- Pulmonary Therapy, 2020, v. 6, n. 2, p. 261, doi. 10.1007/s41030-020-00122-9
- By:
- Publication type:
- Article
15
Burden of Asthma in Elderly Japanese Patients: Using Hospital-Based Administrative Claims Data.
- Published in:
- Pulmonary Therapy, 2020, v. 6, n. 2, p. 247, doi. 10.1007/s41030-020-00121-w
- By:
- Publication type:
- Article
16
Maintenance Therapy with Nebulizers in Patients with Stable COPD: Need for Reevaluation.
- Published in:
- Pulmonary Therapy, 2020, v. 6, n. 2, p. 177, doi. 10.1007/s41030-020-00120-x
- By:
- Publication type:
- Article
17
Alpha 1 "Hereditary Emphysema" Experience: A Patient–Physician Perspective.
- Published in:
- Pulmonary Therapy, 2020, v. 6, n. 2, p. 193, doi. 10.1007/s41030-020-00119-4
- By:
- Publication type:
- Article
18
A Review: Does Complement or the Contact System Have a Role in Protection or Pathogenesis of COVID-19?
- Published in:
- Pulmonary Therapy, 2020, v. 6, n. 2, p. 169, doi. 10.1007/s41030-020-00118-5
- By:
- Publication type:
- Article
19
Forced Expiratory Flow (FEF<sub>25–75%</sub>) as a Clinical Endpoint in Children and Adolescents with Symptomatic Asthma Receiving Tiotropium: A Post Hoc Analysis.
- Published in:
- Pulmonary Therapy, 2020, v. 6, n. 2, p. 151, doi. 10.1007/s41030-020-00117-6
- By:
- Publication type:
- Article